KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cme (CME) Change in Receivables (2016 - 2025)

Cme (CME) has disclosed Change in Receivables for 17 consecutive years, with -$2.8 million as the latest value for Q4 2025.

  • On a quarterly basis, Change in Receivables rose 94.98% to -$2.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $67.1 million, a 70.3% increase, with the full-year FY2025 number at $67.1 million, up 70.3% from a year prior.
  • Change in Receivables was -$2.8 million for Q4 2025 at Cme, up from -$25.5 million in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $241.2 million in Q1 2023 to a low of -$125.5 million in Q2 2023.
  • A 5-year average of $12.7 million and a median of -$24.4 million in 2023 define the central range for Change in Receivables.
  • Peak YoY movement for Change in Receivables: crashed 6700.0% in 2023, then surged 172.79% in 2024.
  • Cme's Change in Receivables stood at -$36.1 million in 2021, then tumbled by 166.76% to -$96.3 million in 2022, then skyrocketed by 75.7% to -$23.4 million in 2023, then crashed by 138.46% to -$55.8 million in 2024, then soared by 94.98% to -$2.8 million in 2025.
  • Per Business Quant, the three most recent readings for CME's Change in Receivables are -$2.8 million (Q4 2025), -$25.5 million (Q3 2025), and -$101.4 million (Q2 2025).